Monday, November 16, 2026 Vol. I · No. 4
Health · Via STAT

STAT+: Bladder cancer immunotherapy from CG Oncology reduced risk of tumor recurrence

Image: STAT

CG Oncology's bladder cancer immunotherapy reduced risk of tumor recurrence by 68% — results that may change how physicians treat certain patients.

This is a brief. The reporting belongs to STAT — read the complete story, with full context and credits, at the source.

Read the full story at STAT ↗

statnews.com

More from the Health desk